why choose us

First received: January 19, 2023

Clinical Trial: Evaluation of the Pharmacokinetics and Safety of VX 548 in Participants With Renal Impairment

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pain

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Study to Evaluate the Pharmacokinetics and Safety of Single Doses of VX-548 in Subjects With Severe or Moderate Renal Impairment and in Matched Healthy Subjects

Brief Summary: The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of VX-548 and its metabolite in participants with severe or moderate renal impairment and healthy participants.

Read more